Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer

Since nanoparticle albumin-bound (nab)-paclitaxel exerts clinically meaningful antitumor effects on various malignancies, including breast, gastric and non-small-cell lung cancer, we hypothesized that treatment with nab-paclitaxel may also be beneficial for patients with small-cell lung cancer (SCLC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Clin Oncol
Main Authors: YOSHIDA, HIRONORI, KIM, YOUNG HAK, OZASA, HIROAKI, NAGAI, HIROKI, SAKAMORI, YUICHI, NAKAOKU, TAKASHI, YAGI, YOSHITAKA, TSUJI, TAKAHIRO, NOMIZO, TAKASHI, MISHIMA, MICHIAKI
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2016
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4906929/
https://ncbi.nlm.nih.gov/pubmed/27330801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.887
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares